Osaic Holdings’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15
Closed 7679
2022
Q4
$0 Hold
15
﹤0.01% 7622
2022
Q3
$0 Hold
15
﹤0.01% 7678
2022
Q2
$0 Hold
15
﹤0.01% 7755
2022
Q1
$0 Hold
15
﹤0.01% 7719
2021
Q4
$0 Hold
15
﹤0.01% 7714
2021
Q3
$0 Hold
15
﹤0.01% 7421
2021
Q2
$0 Hold
15
﹤0.01% 7219
2021
Q1
$0 Buy
+15
New +$133 ﹤0.01% 7025
2020
Q4
Sell
-375
Closed -$4K 6682
2020
Q3
$4K Buy
+375
New +$3.84K ﹤0.01% 5679

Other funds holding MTCR

Osaic Holdings's MTCR Position: Q1 2023 in Review

Osaic Holdings sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 15 shares.

Osaic Holdings first reported a position in MTCR in Q3 2020 and held it in 9 quarters. The position peaked at $4K in Q3 2020. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.

  • Osaic Holdings reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Osaic Holdings sold 15 Metacrine, Inc. Common Stock shares in Q1 2023.
  • Osaic Holdings first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Osaic Holdings's Metacrine, Inc. Common Stock position peaked at $4K in Q3 2020.
  • 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.